Shopping Cart (0)
My Account

Shopping Cart
3 for 2 Offer SELECTBIO Conferences Biomarkers - From Research To CommercializationHigh-Content and Phenotypic Screening Europe 2018Stem Cells and Antibodies in Drug Discovery Europe 2018Antibody Drug ConjugatesOrgan-on-a-Chip, Tissue-on-a-Chip Europe 2018ePoster Award Prize

Business Courses

MicroRNA and Epigenetics: The Research Market, Diagnostics, and Therapeutics


This Business Course is being held in Daejeon, South Korea on the 13 November 2012 at 18:00-19:30

Price:



Enal Razvi Image
Enal Razvi
Managing Director,
Select Biosciences Inc

This course is designed to provide a comprehensive analysis of the current state of the microRNA and epigenetics fields focusing upon the underlying science, emerging trends in technology development, the competitive environment, and market metrics.

microRNAs

Exosomes

Epigenetics

  • Biological Significance and Role
  • Utility of Expression Patterns/Signatures as a Determinant for Physiological Processes as well as Disease/Pathological Situations
  • Technologies for Studying microRNAs and Epigenetic Modifications
  • The Competitive Environment
  • Market Metrics
  • Diagnostics: Role of Circulating microRNAs and Methylated Biomarkers as Potential Disease Markers with Prognostic or Predictive Value
  • Exosomes
  • Therapeutics
    • microRNAs as Therapeutics: Analysis of the Clinical Trial Pipeline, Companies in the Field, and Therapeutic Areas Addressed
    • Epigenetic Modifications as Potential Therapeutics: A number of companies are embarking on therapeutic programs focusing on chromatin-modifying enzymes as targets—These companies and their areas of focus will be analyzed

This training course is ideally suited for researchers involved in investigations focusing on microRNAs or epigenetic changes in biological and disease situations—both academic as well as from the industrial community. Also, this course is important for biotechnology, pharmaceutical, and related disciplines wherein industry participants—both technically focused as well as business focused—can get a solid understanding of the marketplace as well as receive the most up-to-date market data and associated materials for in-house research and business planning activities. Also, this course is recommended for investors as well as attorneys looking for a current technology and market review of this expanding field.

All attendees to this training course receive the electronic files of the presentation material on disk with full rights to use them in their internal R&D as well as business planning activities.

Training Course Specific Presentation Topics

  • MicroRNA Expression Profiles and Epigenetic Modifications in vivo:  Biological Significance and Association with Disease Processes
  • Technologies for Studying microRNA Expression Profiles and Function
  • Technologies for Identifying Epigenetic Modifications
  • Competitive Landscape of Research Tools and Technologies, Quantitative Market Penetrance
  • Market Metrics
    • Market Size
    • Growth Rates
    • Industry SWOT by Segment
  • Association of Specific Signatures [microRNA or Epigenetic] with Specific Physiological or Pathological Events
    • Cancer
    • Cardiovascular Disease
    • CNS Disease
  • MicroRNAs  as Circulating Cancer Biomarkers
    • Diagnostics Applications and Pipeline
    • Therapeutics: Disease Classes, Targets, Clinical Status
  • Epigenetics
    • Development as Diagnostic Biomarkers
    • Utility for Therapeutics Development
    • Targets Addressed in R&D Efforts by Emerging Companies

For more information about this training course or for group registrations, please e-mail Kathy Gray at Kathy.Gray@SelectBiosciences.com